Demand for prophylaxis after bioterrorism-related anthrax cases, 2001

Abstract

Media reports suggested increased public demand for anthrax prophylaxis after the intentional anthrax cases in 2001, but the magnitude of anthrax-related prescribing in unaffected regions was not assessed. We surveyed a random sample of 400 primary care clinicians in Minnesota and Wisconsin to assess requests for and provision of anthrax-related antimicrobial agents. The survey was returned by 239 (60%) of clinicians, including 210 in outpatient practice, Fifty-eight (28%) of those in outpatient practice received requests for anthrax-related antimicrobial agents, and 9 (4%) dispensed them, Outpatient fluoroquinolone use in both states was also analyzed with regression models to compare predicted and actual use in October and November 2001, Fluoroquinolone use as a proportion of total antimicrobial use was not elevated, and anthrax concerns accounted for an estimated 0.3% of all fluoroquinolone prescriptions, Most physicians in Minnesota and Wisconsin managed anthrax-related requests without dispensing antimicrobial agents.